Bill Text: CT HB05962 | 2017 | General Assembly | Comm Sub
Bill Title: An Act Prohibiting Insurers From Using Step Therapy For Prescription Drugs Prescribed To Treat Stage Iv Metastatic Cancer.
Spectrum: Committee Bill
Status: (Introduced - Dead) 2017-03-17 - Favorable Change of Reference, Senate to Committee on Appropriations [HB05962 Detail]
Download: Connecticut-2017-HB05962-Comm_Sub.html
General Assembly |
||
January Session, 2017 |
*_____HB05962INSAPP031017____* |
AN ACT PROHIBITING INSURERS FROM USING STEP THERAPY FOR PRESCRIPTION DRUGS PRESCRIBED TO TREAT STAGE IV METASTATIC CANCER.
Be it enacted by the Senate and House of Representatives in General Assembly convened:
Section 1. Subsection (a) of section 38a-510 of the general statutes is repealed and the following is substituted in lieu thereof (Effective January 1, 2018):
(a) No insurance company, hospital service corporation, medical service corporation, health care center or other entity delivering, issuing for delivery, renewing, amending or continuing an individual health insurance policy or contract that provides coverage for prescription drugs may:
(1) Require any person covered under such policy or contract to obtain prescription drugs from a mail order pharmacy as a condition of obtaining benefits for such drugs; or
(2) Require, if such insurance company, hospital service corporation, medical service corporation, health care center or other entity uses step therapy for such drugs, the use of step therapy for (A) any prescribed drug for longer than sixty days, or (B) any drug prescribed for cancer treatment to an insured who has been diagnosed with stage IV metastatic cancer. At the expiration of [such] the time period, an insured's treating health care provider may deem such step therapy drug regimen clinically ineffective for the insured, at which time the insurance company, hospital service corporation, medical service corporation, health care center or other entity shall authorize dispensation of and coverage for the drug prescribed by the insured's treating health care provider, provided such drug is a covered drug under such policy or contract. If such provider does not deem such step therapy drug regimen clinically ineffective or has not requested an override pursuant to subdivision (1) of subsection (b) of this section, such drug regimen may be continued. For purposes of this section, "step therapy" means a protocol or program that establishes the specific sequence in which prescription drugs for a specified medical condition are to be prescribed.
Sec. 2. Subsection (a) of section 38a-544 of the general statutes is repealed and the following is substituted in lieu thereof (Effective January 1, 2018):
(a) No insurance company, hospital service corporation, medical service corporation, health care center or other entity delivering, issuing for delivery, renewing, amending or continuing a group health insurance policy or contract that provides coverage for prescription drugs may:
(1) Require any person covered under such policy or contract to obtain prescription drugs from a mail order pharmacy as a condition of obtaining benefits for such drugs; or
(2) Require, if such insurance company, hospital service corporation, medical service corporation, health care center or other entity uses step therapy for such drugs, the use of step therapy for (A) any prescribed drug for longer than sixty days, or (B) any drug prescribed for cancer treatment to an insured who has been diagnosed with stage IV metastatic cancer. At the expiration of [such] the time period, an insured's treating health care provider may deem such step therapy drug regimen clinically ineffective for the insured, at which time the insurance company, hospital service corporation, medical service corporation, health care center or other entity shall authorize dispensation of and coverage for the drug prescribed by the insured's treating health care provider, provided such drug is a covered drug under such policy or contract. If such provider does not deem such step therapy drug regimen clinically ineffective or has not requested an override pursuant to subdivision (1) of subsection (b) of this section, such drug regimen may be continued. For purposes of this section, "step therapy" means a protocol or program that establishes the specific sequence in which prescription drugs for a specified medical condition are to be prescribed.
This act shall take effect as follows and shall amend the following sections: | ||
Section 1 |
January 1, 2018 |
38a-510(a) |
Sec. 2 |
January 1, 2018 |
38a-544(a) |
INS |
Joint Favorable Subst. C/R |
APP |